Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data.
Irene Toribio-GarcíaAlejandro Olivares-HernándezJosé Pablo Miramontes GonzálezLuis Posado DomínguezAna Martín GarcíaRocio EirosLuis Figuero PérezMaría Garijo MartínezJonnathan Roldán RuizLorena Bellido HernándezEmilio Fonseca-SánchezPedro Luis SánchezEdel Del Barco-MorilloPublished in: Cancers (2023)
Immunotherapy is shown to be a safe treatment in elderly cancer patients in terms of cardiotoxicity. The event rate shows no difference between patients with or without cardiac comorbidity.